Rhenman & Partners Asset Management AB »

Augmedix shares owned by Rhenman & Partners Asset Management AB

Quarter-by-quarter ownership of Augmedix (AUGX) shares owned by Rhenman & Partners Asset Management AB from 13F filings

Historical chart of Rhenman & Partners Asset Management AB investment in Augmedix

Tip: Access up to 7 years of quarterly data

All positions including Augmedix held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Augmedix by Rhenman & Partners Asset Management AB

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.3M 800k 4.09

More positions owned by Rhenman & Partners Asset Management AB

Cigna Corp (CI)
Eli Lilly & Co. (LLY)
Tenet Healthcare Corp Com New (THC)
Boston Scientific Corporation (BSX)
Anthem (ELV)
Abbvie (ABBV)
Hca Holdings (HCA)
Regeneron Pharmaceuticals (REGN)
Cooper Cos (COO)
Merck & Co (MRK)
Becton, Dickinson and (BDX)
Medtronic SHS (MDT)
Oscar Health Cl A (OSCR)
Procept Biorobotics Corp (PRCT)
McKesson Corporation (MCK)

View all positions for Rhenman & Partners Asset Management AB

Top funds holding Augmedix

Redmile Group
Samjo Management
Citadel Advisors
Perkins Capital Management
Vanguard Group
Balyasny Asset Management
Parkman Healthcare Partners
Millennium Management
Caption Management
Rhenman & Partners Asset Management AB
Russell Investments
G2 Investment Partners Management
Essex Investment Management
Ardsley Advisory Partners
American Financial Group

View all funds holding Augmedix